Navigation Links
Labopharm Appeals FDA's Decision on Once-Daily Tramadol to Next Supervisory Level After Additional Analysis Supports Efficacy
Date:4/1/2008

- Company Believes That Continuing to Follow Dispute Resolution Process is

the Most Expeditious Path to Final Approval -

LAVAL, QC, April 1 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that it has appealed the U.S. Food and Drug Administration's (FDA) decision on its once-daily tramadol formulation to the next supervisory level under the FDA's Formal Dispute Resolution process. Labopharm's continuation of the appeal process follows the completion of additional statistical analysis of existing data per the suggestion of Dr. John K. Jenkins, M.D., the FDA's Director for the Office of New Drugs, Center for Drug Evaluation and Research, as a means to potentially satisfy the FDA's requirements for regulatory approval. The Company believes that the additional analysis confirms the conclusions of efficacy of its once-daily tramadol formulation as demonstrated in previous analyses that were included in its New Drug Application (NDA) and additional submissions thereafter.

"We have maintained the position that our strong body of data warrants the approval of our once-daily tramadol formulation and believe that the additional analysis we conducted as proposed by the FDA confirms our position," said James R. Howard-Tripp, President and Chief Executive Officer, Labopharm Inc. "We believe that continuing the Formal Dispute Resolution process, as opposed to submitting a complete response, is the most appropriate path to resolving the outstanding matter and achieving our objective of commercialization in the United States."

As part of the appeal process, Labopharm has requested a meeting with Dr. Janet Woodcock, M.D., the FDA's Director, Center for Drug Evaluation and Research. The Agency usually grants such requests within 30 days and typically provides a written response to the appellant within 30 days of a meeting.

About the FDA's Formal Dispute Resolution Process

FDA regulations provide
'/>"/>

SOURCE Labopharm Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen
2. Labopharms Once-Daily Tramadol Approved in South Korea and Australia
3. Labopharm to host conference call Thursday, February 21, 2008 at 8:30 a.m. (ET)
4. Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone
5. Canadian Marketing and Sales Effort for Labopharms Once-Daily Tramadol Product to Expand Significantly
6. Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova
7. Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
8. Labopharm Reports Results for Third Quarter Fiscal 2007
9. Labopharm to present at CIBC World Markets 18th Annual Healthcare Conference
10. Labopharm to host conference call Friday, November 9, 2007 at 8:30 a.m. (ET)
11. Labopharm appeals FDAs decision on once-daily tramadol
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... Range Kleen Mfg. strives to “TCOTC.” Our number one ... President's desk to the Shipping Dock.” We hold high in ... passion while creating excellence and quality being results oriented. It ... the right thing and what better way to help with ... , Throughout the year Range Kleen donates to numerous local ...
(Date:5/24/2013)... HealthDay Reporter , , FRIDAY, May 24 (HealthDay News) -- ... But it was a physical challenge in her childhood ... sport. "I was an 11-year-old girl with my ... diagnosed by my orthopedic surgeon," said Lewis, who has ... and the American Academy of Orthopaedic Surgeons so she ...
(Date:5/24/2013)... 24, 2013 With Memorial Day Weekend upon ... Insurance is offering tips to help prevent grill fires ... Protection Association (NFPA) reports that gas grills led to ... Charcoal or other solid-fueled grills, meanwhile, caused approximately 1,200 home ... result, Amica Insurance is sharing the following tips from the ...
(Date:5/24/2013)... Portland, OR (PRWEB) May 24, 2013 ... and Sustainable Cards, major competitors in sustainable card ... awareness of using forest materials as a sustainable ... committee is to identify industry challenges and increase ... gift card programs to support the reduction of ...
(Date:5/24/2013)... 2013 Area homeowners dreaming about owning a ... tubs to choose from at factory-direct pricing during the ... event takes place at Emerald Pool and Patio ... Jacuzzi, the industry's leading hot tub brand, scheduled the event ... The event will feature popular hot tub models at up ...
Breaking Medicine News(10 mins):Health News:Range Kleen Partners with Berndes in Red Cross Promotion: Taking Care of Oklahoma 2Health News:Top-Ranked Golfer Beats Scoliosis 2Health News:Top-Ranked Golfer Beats Scoliosis 3Health News:Don’t Get Burned: Five Grilling Tips from Amica Insurance 2Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 2Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 3Health News:Truckload of Jacuzzi® Hot Tubs Rolls into Bend, Oregon on May 24, 2013 for Sales Event 2
... the continued presence of a doula an experienced non-medical ... beneficial effects for middle- and upper-class women in childbirth, even ... with them, according to a new study in the journal ... of 420 pregnant women in their third trimester were randomized ...
... CHESTNUT HILL, MA A critical enzyme used to ... help drug makers better target the cells the natural ... 23 edition of the Journal of Biological Chemistry. , ... of researchers from Boston College and the University of ...
... WILMINGTON, Del., May 29 AARP announced today ... reveals concerns,regarding health care access and affordability. AARP presented ... needs and disparities in,Delaware. View Delaware Health Care: A ... ., The key survey findings show that controlling ...
... 29 PartnerRe Ltd.,(NYSE: PRE ) today announced ... is scheduled to present at the Fox,Pitt-Kelton Cochran Caronia ... for the Insurers... and the Contrast with,Banks." The half-day ... 2008 from 9 a.m. - 2 p.m. local time ...
... N.C., May 29 Quality projects are not ... not,breakthroughs. However, these increments can grow to be ... had median savings of $1.2,million from their largest-impact ... complimentary excerpt "Transforming the Supply Chain: The,Impact of ...
... 60 Different Medical and Aesthetic ... ... Ltd. ("Alma Lasers"), a,global developer and marketer of laser, light, and ... clearance,for its Harmony(XL), the newest platform for multiple aesthetic laser and,light ...
Cached Medicine News:Health News:Enzyme may hold key to improved targeting of cancer-fighting drugs 2Health News:AARP Survey Reveals Boomers' Health Care Needs in Delaware 2Health News:AARP Survey Reveals Boomers' Health Care Needs in Delaware 3Health News:PartnerRe Executive Vice President & Chief Financial Officer Albert Benchimol to Present at the FPK CCW Credit Risk Conference in London on June 6, 2008 2Health News:Alma Lasers Announces FDA Clearance of the Harmony(XL) Multi-Application System at THE Aesthetic Show 2008 2
(Date:5/24/2013)... , May 24, 2013  Sinovac Biotech Ltd. ... of biopharmaceutical products in China ... subsidiary company of Sinovac, obtained the Certificate of ... from the China State and Food Administration (CFDA) ... production plants, and its Changping filing and packaging ...
(Date:5/23/2013)... CHINA , May 24, 2013 ... or the "Company"), a leading China ... manufacturing and marketing biopharmaceutical products, announced today that, ... "EGM"), the Company,s shareholders voted in favor of ... announced agreement and plan of merger dated February ...
(Date:5/23/2013)... -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced ... Chief Executive Officer of Neurocrine Biosciences, will be presenting at ... Conference in Boston.   The live presentation takes ... / 8:20 a.m. Pacific Time.  The presentation will be webcast ... http://www.neurocrine.com . If you are unable to ...
Breaking Medicine Technology:Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 33SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3
... N.Y., Feb. 21, 2012  Regeneron Pharmaceuticals, Inc. (Nasdaq: ... following investor conferences: , Citi 2012 Global Healthcare ... 28, 2012 , RBC Capital Markets, Healthcare Conference ... 2012 The sessions may be accessed through ...
... PHILADELPHIA, Pennsylvania and WALTHAM, Massachusetts, February 21, 2012 ... clinical decision support content and analytics tools into ... Elsevier , a world-leading provider of scientific, ... PatientKeeper ®, the leading provider of physician ...
Cached Medicine Technology:Regeneron Announces February 2012 Investor Conference Presentations 2Elsevier Integrates its Clinical Decision Support Solutions Into PatientKeeper CPOE 2Elsevier Integrates its Clinical Decision Support Solutions Into PatientKeeper CPOE 3Elsevier Integrates its Clinical Decision Support Solutions Into PatientKeeper CPOE 4
... Diagnostics Histoplasma DxSelect is intended for qualitatively ... in human serum. The test is indicated ... disease, as an aid in the presumptive ... is not intended for self-testing, and this ...
... Indirect immunofluorescent antibody (IFA) ... and semi-quantitation of human ... Epstein-Barr viral capsid antigen ... ten 12-well slides, FITC ...
... portable, battery-powered, micro-controlled, noninvasive bone growth stimulator ... primary lumbar spinal fusion surgery for one ... been shown in pre-clinical studies to help ... Clinical studies have also shown that individuals ...
... Medical Solutions introduces its new multifunctional ... with intuitive patient data management is ... and urological table. Lithoskop is an ... that covers all applications like lithotripsy, ...
Medicine Products: